A newly published analysis has reinforced findings that daily coffee consumption is associated with lower risks of liver cancer and fatal cirrhosis. The research follows a series of similar studies reported over the past decade.

The analysis, drawing on large observational cohorts, found that people who drank several cups of coffee daily had reduced rates of hepatocellular carcinoma and chronic liver disease compared with non-drinkers. Both caffeinated and decaffeinated coffee appeared to offer benefits, suggesting compounds beyond caffeine may play a role.

Hepatology specialists cautioned that observational data cannot prove that coffee directly prevents disease, because coffee drinkers may differ from abstainers in other lifestyle factors. Dietitians noted that adding sugar, cream and syrups can offset any potential health advantage.

Public interest in coffee's health effects continues to rise, with cafes and health publications frequently citing earlier studies linking the drink to lower rates of type 2 diabetes and cardiovascular disease. Liver disease remains a growing global health burden, driven partly by obesity and alcohol consumption.

Researchers said further controlled trials would be needed before any dietary recommendations could change, urging moderation rather than dramatic increases in intake. They stressed that reducing alcohol and maintaining a healthy weight remained the most effective ways to protect the liver.